Acinetobacter baumannii is a member of the ESKAPE pathogens, notorious for causing multidrug resistant nosocomial infections worldwide. Biofilm has an important role in its persistence and spread in hospital environment, as well as its multidrug resistance potential. The present study was aimed at finding out whether the strength of Biofilm formation varies with infection of different organs / system. A total of 136 isolates of Acinetobacter baumannii were taken from a variety of samples. Strength of Biofilm formation, determined by Tissue culture plate method, was graded according to OD value in ELISA reader as nil, moderate and strong. It was seen that association between variations in biofilm forming capacity depending on different sites of infection was statistically significant. We suggest biofilm typing by this method for this pathogen, as a potentially feasible alternative in countries with cost restrained healthcare set ups. Moreover, biofilm typing report would be more meaningful to the clinicians as well.
Tommasi R, Brown DG, Walkup GK, Manchester JI, Miller AA. ESKAPEing the labyrinth of antibacterial discovery. Nat Rev Drug Discov. 2015;14:529–542.
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016 Feb;16(2):161-68. doi: 10.1016/S1473-3099(15)00424-7.
Gandra S, Tseng KK, Arora A, Bhowmik B, Robinson ML, Panigrahi B, Laxminarayan R, Klein EY. The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study. Clin Infect Dis. 2015;69(4):563–70.
Chakraborty B, Banerjee D, Chakraborty B. Acinetobacter baumannii: No more a choosy intruder? Indian J Med Sci. 2011;65:344-48.
Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, Urban CM, Spellberg BJ, Rhee D, Halstead DC, Pasculle AW, Doi Y. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol. 2011;49(11):3849-54.
Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12:826-836.
Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 2014;37:119-127.
Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol. 2008;26: 333-337.
Donlan R. Costerton J. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clin Microbiol Rev. 2002;15:167-193.
Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A. Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol. 2008;24:25-29.
Kwasny S, Opperman J. Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery. Curr Protoc Pharmacol. 2010 Sep 1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272335.
Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime–producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982;37:318–26.
Panda P, Chaudhary U, Dube S. Comparison of four different methods for detection of biofilm formation by uropathogens. Indian J Pathol Microbiol. 2016;59:177-179.
Gallagher LA, Ramage E, Weiss EJ, Radey M, Hayden HS et al. Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii. J Bacteriol. 2015;197(12):2027-35.
This work is licensed under a Creative Commons Attribution 4.0 International License.